Showing results (91-100 of 274) with videos related to
Sort By:
Pageof 28
Frontiers in Pharmacology|November 9, 2023
Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trialsYuxiao Li, Jingya Yang, Chi Ian Chau, et al.Therapeutic Advances in Medical Oncology|March 2, 2016
Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinomaNoelia Tarazona, Elizabeth C Smyth, Clare Peckit, et al.Diseases of the Colon and Rectum|September 10, 2011
Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?Jessica Evans, Diana Tait, Ian Swift, et al.The Oncologist|February 18, 2017
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer PatientsFrancesco Sclafani, Federica Morano, David Cunningham, et al.Hematology (Amsterdam, Netherlands)|April 25, 2007
Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL)Bhawna Sirohi, David Cunningham, Andy Norman, et al.Anticancer Research|October 3, 2018
Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary CentreAvani Athauda, David Watkins, Kabir Mohammed, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancerNaureen Starling, David Watkins, David Cunningham, et al.Clinical Colorectal Cancer|October 2, 2012
Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resectionAnastasia Constantinidou, David Cunningham, Fatima Shurmahi, et al.Current Oncology (Toronto, Ont.)|June 25, 2026
Targeting Phosphatidylserine in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas: A Phase 2 Trial of Bavituximab Plus Pembrolizumab with Biomarker-Correlated OutcomesPanagiotis Ntellas, Haeseong Park, Kerry Culm, et al.Quantitative Imaging in Medicine and Surgery|August 3, 2021
Whole-body diffusion-weighted MRI in lymphoma-comparison of global apparent diffusion coefficient histogram parameters for differentiation of diseased nodes of lymphoma patients from normal lymph nodes of healthy individualsRicardo Donners, Raphael Shih Zhu Yiin, Dow-Mu Koh, et al.Pageof 28